Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
- DKK | -.--% | -.--% | -0,50 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stacy Wheeler
COO | Chief Operating Officer | - | 01/03/16 |
Chief Tech/Sci/R&D Officer | - | 13/09/17 | |
Lionel Rostaing
PRN | Corporate Officer/Principal | - | - |
Josep Grinyo
PRN | Corporate Officer/Principal | - | - |
Noel Barnard
LAW | General Counsel | - | 01/03/16 |
Mark Hensley
PRN | Corporate Officer/Principal | - | 01/04/16 |
Rita L. Mannella
HRO | Human Resources Officer | - | 01/01/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 739 741 590 | 173 932 405 ( 9,998 %) | 0 | 9,998 % |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The private company is based in Edison, NJ. |
Pharmaceuticals: Major
|
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-0,50 % | 1644,13 M | |
+5,31 % | 70,44 mil M | |
+10,97 % | 8939,13 M | |
-16,83 % | 4750,81 M | |
+43,48 % | 4497,76 M | |
+3,20 % | 3845,87 M | |
+18,82 % | 2375,28 M | |
-21,36 % | 2341,22 M | |
-29,67 % | 2196,26 M | |
+8,38 % | 1963,71 M |
- Bolsa de valores
- Acciones
- Acción VELO
- Empresa Veloxis Pharmaceuticals A/S